Effects of Endocrine-Disrupting Chemicals on Bone Health
Endocrinology and Metabolism · 31.08.2024 · 39 (4) · 539-551
DOI: 10.3803/enm.2024.1963 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism, erschienen am 31.08.2024. Verfasst von So Young Park und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, College of Medicine, Kyung Hee University, Seoul, Korea. Hauptthemen laut MEDLINE: Endocrine Disruptors, Phthalic Acids, Bone and Bones, Benzhydryl Compounds. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This comprehensive review critically examines the detrimental impacts of endocrine-disrupting chemicals (EDCs) on bone health, with a specific focus on substances such as bisphenol A (BPA), per- and polyfluoroalkyl substances (PFASs), phthalates, and dioxins. These EDCs, by interfering with the endocrine system’s normal functioning, pose a significant risk to bone metabolism, potentially leading to a heightened susceptibility to bone-related disorders and diseases. Notably, BPA has been shown to inhibit the differentiation of osteoblasts and promote the apoptosis of osteoblasts, which results in altered bone turnover status. PFASs, known for their environmental persistence and ability to bioaccumulate in the human body, have been linked to an increased osteoporosis risk. Similarly, phthalates, which are widely used in the production of plastics, have been associated with adverse bone health outcomes, showing an inverse relationship between phthalate exposure and bone mineral density. Dioxins present a more complex picture, with research findings suggesting both potential benefits and adverse effects on bone structure and density, depending on factors such as the timing and level of exposure. This review underscores the urgent need for further research to better understand the specific pathways through which EDCs affect bone health and to develop targeted strategies for mitigating their potentially harmful impacts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, College of Medicine, Kyung Hee University, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
- Department of Endocrinology and Metabolism, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.
- Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Zitieren
APA
Park, S. Y., Kong, S. H., Kim, K. J., Ahn, S. H., Hong, N., Ha, J., Lee, S., Choi, H. S., Baek, K. H., Kim, J. E., & Kim, S. W. (2024). Effects of Endocrine-Disrupting Chemicals on Bone Health. Endocrinology and Metabolism, 39(4), 539-551. https://doi.org/10.3803/enm.2024.1963
Vancouver
Park SY, Kong SH, Kim KJ, Ahn SH, Hong N, Ha J, et al. Effects of Endocrine-Disrupting Chemicals on Bone Health. Endocrinology and Metabolism. 2024;39(4):539-551. doi:10.3803/enm.2024.1963
BibTeX
@article{Park2024,
author = {Park, So Young and Kong, Sung Hye and Kim, Kyoung Jin and Ahn, Seong Hee and Hong, Namki and Ha, Jeonghoon and Lee, Sihoon and Choi, Han Seok and Baek, Ki-Hyun and Kim, Jung-Eun and Kim, Sang Wan},
title = {Effects of Endocrine-Disrupting Chemicals on Bone Health},
journal = {Endocrinology and Metabolism},
year = {2024},
volume = {39},
number = {4},
pages = {539--551},
doi = {10.3803/enm.2024.1963}
}
EUVIMED